Ledger.Open graph →
SEC Form D · filed November 18, 2021

Revelar Biotherapeutics, Inc

Offering
$22.5M
Sold
$17.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BETHESDA, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Paul Fonteyne · Bethesda, MDDirectorLaurence Smith · Bethesda, MDExecGlenn Marina · Bethesda, MDExec · DirectorBrett Giroir · Bethesda, MDDirectorDavid Scheer · Branford, CTDirectorRahima H. Blaza · Tempe, AZExec · DirectorOliver Holle · Vienna, C4DirectorSal Guy · Henderson, NVExecLuyu Yang · BELLEVUE, WADirectorJason Witherspoon · Groesbeck, TXExecDaniel S. Short · San Francisco, CAExec · DirectorHannah S. Dunn · San Francisco, CADirectorJoshua S. Dapice · San Francisco, CADirectorDavid Scheer · Winston-Salem, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗